Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sintilimab

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Tyvyt

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Tyvyt

    Sintilimab

    arrow
    American Pharma Summit
    Not Confirmed

    Brand Name : Tyvyt

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Eli Lilly

    Sintilimab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 418

    2020 Revenue in Millions : 309

    Growth (%) : 35

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Tyvyt

    Sintilimab

    arrow
    American Pharma Summit
    Not Confirmed

    Brand Name : Tyvyt

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Eli Lilly

    Sintilimab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 293

    2021 Revenue in Millions : 418

    Growth (%) : -30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tyvyt

    Sintilimab

    arrow
    American Pharma Summit
    Not Confirmed

    Brand Name : Tyvyt

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Eli Lilly

    Sintilimab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 393

    2022 Revenue in Millions : 293

    Growth (%) : 34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF